HSP90-IN-31 reduces CD80 and CD86 expression on dendritic cells (DCs); suppresses the production of pro-inflammatory cytokines (IL-6, TNF-α, and IL-1β) in LPS-stimulated bone marrow-derived dendritic cells (BMDCs) and peritoneal macrophages; and alleviates ear swelling and pro-inflammatory cytokine levels in the spleen in a delayed-type hypersensitivity (DTH) mouse model.